Omniab Inc (OABI)

R&D to Revenue

71.46%

Quarterly · Period ending:

OABI logo

OABI R&D to Revenue

Latest reported71.46%
OABI Quarterly R&D/Revenue (151.23% → 71.46%)
High-resolution chart · PNG

OABI r&d to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Omniab Inc R&D to Revenue — Quarterly
Period endingR&D to Revenue
71.4573%
66.6667%
166.0578%
463.5552%
278.7785%
303.3702%
123.1581%
319.2234%
183.0181%
382.8203%
306.2215%
253.1861%
203.4696%
81.3228%
36.5511%
190.8683%
159.5222%
111.9401%
72.1531%
158.1169%
160.0895%
138.5945%
55.1696%
151.2332%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.